Clinical Trials on ALK Positive Malignancies
Total 433008 results
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalNot yet recruitingCD19-positive Relapsed or Refractory B-cell MalignanciesChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
Amsterdam UMC, location VUmcCompletedColorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced MalignanciesNetherlands
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
AHS Cancer Control AlbertaCross Cancer InstituteWithdrawnMetastatic Solid Malignancies | Locally Advanced Solid MalignanciesCanada
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
Ospedale Santa Croce-Carle CuneoUnknownAdvanced Haematological Malignancies | High Risk Haematological MalignanciesItaly
-
Astellas Pharma IncCompletedSolid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROSUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingTotal Exenteration | Anterior or Posterior Pelvic Exenteration | Gynecologic Malignancies | Colorectal Malignancies | Urologic MalignanciesUnited States
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1：r/r B-cell Malignancies | Part 2：B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Regeneron PharmaceuticalsSanofiActive, not recruitingMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
MEI Pharma, Inc.Quotient ClinicalCompleted
-
Pathway Therapeutics, Inc.Completed
-
AgennixTerminatedMalignanciesUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Xiao ChenRecruitingHepatic MalignanciesChina
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced MalignanciesChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Zhujiang HospitalGuangzhou BRCompletedHepatobiliary MalignanciesChina
-
Gilead SciencesTerminatedLymphoid MalignanciesNetherlands
-
Southwest Hospital, ChinaUnknown
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
Bristol-Myers SquibbCompletedAdvanced MalignanciesUnited States
-
Symphony Evolution, Inc.Completed
-
University Hospital, Clermont-FerrandAmgenTerminatedSolid Malignancies
-
Shandong New Time Pharmaceutical Co., LTDFudan University; Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingAdvanced Malignancies
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdNot yet recruitingAdvanced MalignanciesChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Sichuan UniversityRecruitingMyeloid MalignanciesChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced MalignanciesChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Case Comprehensive Cancer CenterCompletedHepatic MalignanciesUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced MalignanciesChina